gene expression Jun 22, 2022 Agendia Building Validation Data on ImPrint for Guiding Neoadjuvant Immunotherapy in Breast Cancer Premium Feb 22, 2022 FDA Deems Allarity Therapeutics' Kidney Cancer Drug, CDx Regulatory Applications Incomplete Feb 8, 2022 Biocartis, Ophiomics Partner to Commercialize Gene Expression Prognostic Test for Liver Cancer Nov 17, 2021 Multiple Myeloma Patient Similarity Network Reveals Prognostically Informative Subgroups Sep 21, 2021 Early ESMO Data Show Interferon Signature's Ability to Guide Neoadjuvant Melanoma Immunotherapy Aug 27, 2021 Oncocyte Launches Prospective Registry to Drive DetermaRx Adoption, Improve Coverage Premium Aug 20, 2021 Labcorp, CCORN Ink Partnership to Address Precision Oncology Disparities Jul 6, 2021 FDA Accepts Allarity Therapeutics' PMA for Dovitinib Companion Test Jun 24, 2021 Overexpressed Cancer Testis Antigen Could Reflect Therapeutic Target in Liver Cancer Jun 15, 2021 NanoString Technologies, Parker Institute for Cancer Immunotherapy Partner on Cell Therapy Project May 10, 2021 Medicare Expands Coverage for Hologic's Biotheranostics Breast Cancer Test Apr 27, 2021 BostonGene, Medical College of Wisconsin Partner on Pancreatic Cancer Biomarker Research Apr 13, 2021 Cofactor Genomics Begins Multi-Site Clinical Trial for Immunotherapy Prediction Assay Apr 12, 2021 Oncocyte AACR Data Expands Potential Applications for Immunotherapy Response Predictor Mar 23, 2021 Caris-Led Team Searches for Clues to Poor COVID-19 Outcomes in Cancer Patients' Transcriptome Data Premium Mar 18, 2021 Oncocyte Details New Expansions Plans With Growing Portfolio of Acquired Tests Premium Dec 22, 2020 Agendia FLEX Registry Powers Genomics Research on Underrepresented Breast Cancer Patients Premium Oct 27, 2020 SickKids' 'Rigorous' Molecular Analysis IDs Targetable Alterations, Cancer Susceptibility Mutations Premium Oct 21, 2020 Oncocyte DetermaRx Predicts Early Lung Cancer Outcomes Regardless of EGFR Status Premium Oct 8, 2020 Oncocyte, Fondazione Michelangelo to Evaluate DetermaIO Test for Immunotherapy Response Prediction Load More Breaking News FDA Approves Taiho Oncology's Lytgobi for FGFR2-Rearranged Bile Duct Cancer Gladstone Institute Joins With Parker Institute on New Center to Study CRISPR-Based Cell Therapies Meliora Therapeutics Raises $11M in Seed Financing In Brief This Week:Â Verismo Therapeutics, Fore Biotherapeutics, Merck, Caris Life Sciences Tumor-Only Sequencing Found to Overestimate Mutational Burden in Non-European Patients Atara Biotherapeutics to Net $30M From Pierre Fabre for European Tab-Cel Approval
